[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cibus Inc (CBUS)

Cibus Inc (CBUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 106,101
  • Shares Outstanding, K 76,332
  • Annual Sales, $ 3,640 K
  • Annual Income, $ -127,090 K
  • EBIT $ -59 M
  • EBITDA $ -32 M
  • 60-Month Beta 1.65
  • Price/Sales 29.79
  • Price/Cash Flow N/A
  • Price/Book 3.06

Options Overview Details

View History
  • Implied Volatility 457.00% (-3.29%)
  • Historical Volatility 61.43%
  • IV Percentile 90%
  • IV Rank 46.13%
  • IV High 903.24% on 09/25/25
  • IV Low 74.80% on 10/13/25
  • Expected Move (DTE 13) 1.0200 (73.38%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 160
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 984
  • Open Int (30-Day) 1,078
  • Expected Range 0.3700 to 2.4100

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.31
  • Number of Estimates 2
  • High Estimate $-0.26
  • Low Estimate $-0.35
  • Prior Year $-0.61
  • Growth Rate Est. (year over year) +49.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1700 +18.80%
on 06/11/26
1.5100 -7.95%
on 07/02/26
unch (unch)
since 06/02/26
3-Month
1.1700 +18.80%
on 06/11/26
2.0300 -31.53%
on 04/06/26
-0.5900 (-29.80%)
since 04/02/26
52-Week
1.0900 +27.52%
on 11/14/25
4.1907 -66.83%
on 03/11/26
-0.1200 (-7.95%)
since 07/02/25

Most Recent Stories

More News
Cibus Q1 Earnings Call Highlights

Cibus (NASDAQ:CBUS) reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and extending...

CBUS : 1.3900 (-2.11%)
Cibus: Q1 Earnings Snapshot

Cibus: Q1 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus: Q4 Earnings Snapshot

Cibus: Q4 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus: Q3 Earnings Snapshot

Cibus: Q3 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus: Q2 Earnings Snapshot

Cibus: Q2 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus: Q1 Earnings Snapshot

Cibus: Q1 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus: Q4 Earnings Snapshot

Cibus: Q4 Earnings Snapshot

CBUS : 1.3900 (-2.11%)
Cibus Advances Commercialization of Clethodim-Tolerant HT-3 Rice Trait in Collaboration with Albaugh and RTDC

Cibus advances commercialization of its Clethodim-tolerant HT-3 rice trait through collaborations with Albaugh and RTDC.Quiver AI SummaryCibus, Inc. is making significant strides towards commercializing...

CBUS : 1.3900 (-2.11%)
Insider Sale: Director at $CBUS (CBUS) Sells 2,300 Shares

Gerhard Prante, a director at $CBUS ($CBUS), sold 2,300 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.3% of their shares....

CBUS : 1.3900 (-2.11%)
Cibus and Biographica Collaborate to Enhance Disease Resistance in Oilseed Rape and Canola Through AI and Gene Editing Technology

Cibus and Biographica are collaborating to enhance disease resistance in oilseed rape and Canola using AI-driven gene editing.Quiver AI SummaryCibus, Inc. and Biographica have announced a collaboration...

CBUS : 1.3900 (-2.11%)

Business Summary

Cibus Inc. is an agricultural technology company which develops and licenses plant traits to seed companies for royalties. Cibus Inc., formerly known as Calyxt Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 1.6033
2nd Resistance Point 1.5567
1st Resistance Point 1.4733
Last Price 1.3900
1st Support Level 1.3433
2nd Support Level 1.2967
3rd Support Level 1.2133

See More

52-Week High 4.1907
Fibonacci 61.8% 3.0062
Fibonacci 50% 2.6404
Fibonacci 38.2% 2.2745
Last Price 1.3900
52-Week Low 1.0900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.